Skip to content
    Inve.money
    Earnings calls

    Hester Bios concall ledger

    Every earnings call for HESTERBIO — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    HESTERBIO · 6 transcripts · Healthcare · latest Q4 FY26

    Hester Bios has 6 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.

    Q3 FY26Published 30 Jan 2026Call held 30 Jan 2026

    HESTERBIO Q3 FY26 Earnings Call Transcript & Analysis

    Stand-alone Revenue Growth0.12%+12% YoYStand-alone PAT Growth1.4%+140% YoY9M Stand-alone Revenue Growth-0.05%−5% YoY9M Stand-alone Profit Growth0.16%+16% YoYConsolidated Revenue Growth0.22%+22% YoY

    Stand-alone Revenue Growth 0.12% (+12% YoY); Stand-alone PAT Growth 1.4% (+140% YoY); 9M Stand-alone Revenue Growth -0.05% (−5% YoY). Stand-alone revenue grew 12% in Q3 FY26, with PAT up 140% YoY.

    Read full transcript & analysis
    Q3 FY26Published 02 Feb 2026Call held 02 Feb 2026

    HESTERBIO Q3 FY26 Earnings Call Transcript & Analysis

    Stand-alone Q3 Revenue Growth0.12%+12% YoYStand-alone Q3 PAT Growth1.4%+140% YoYStand-alone 9M Revenue Growth-0.05%−5% YoYStand-alone 9M Profit Growth0.16%+16% YoYConsolidated Q3 Revenue Growth0.22%+22% YoY

    Stand-alone Q3 Revenue Growth 0.12% (+12% YoY); Stand-alone Q3 PAT Growth 1.4% (+140% YoY); Stand-alone 9M Revenue Growth -0.05% (−5% YoY). Q3 stand-alone revenue grew by 12%.

    Read full transcript & analysis